G Walz

Summary

Affiliation: University Hospital
Country: Germany

Publications

  1. ncbi Everolimus in patients with autosomal dominant polycystic kidney disease
    Gerd Walz
    Renal Division, University Hospital Freiburg, Hugstetter St, 55 79106 Freiburg, Germany
    N Engl J Med 363:830-40. 2010
  2. ncbi [Organizational forms of emergency medicine from the viewpoint of hospital management. Discipline-specific or interdisciplinary?]
    G Walz
    Medizinische Klinik IV, Universitatsklinikum, Hugstetter Strasse 55, Freiburg, Germany
    Chirurg 82:342-7. 2011
  3. ncbi Rapidly progressive hepatic alveolar echinococcosis in an ABO-incompatible renal transplant recipient
    M Geyer
    Renal Division, University Hospital Freiburg, Freiburg, Germany
    Transpl Infect Dis 13:278-84. 2011
  4. ncbi ABO-incompatible kidney transplantation with antigen-specific immunoadsorption and rituximab - insights and uncertainties
    M Geyer
    University Hospital Freiburg, Freiburg, Germany
    Contrib Nephrol 162:47-60. 2009
  5. ncbi [Disseminated histoplasmosis with involvement of mediastinum and skin in an immunocompetent patient]
    R Wobser
    Abteilung für Nephrologie und Allgemeinmedizin, Medizinische Klinik IV, Universitatsklinikum Freiburg, Hugstetterstrasse 55, Freiburg
    Dtsch Med Wochenschr 134:589-93. 2009
  6. ncbi Nephrogenic systemic fibrosis following exposure to gadolinium-containing contrast agent
    S Clorius
    Department of Medicine, Renal Division, University Hospital Freiburg, Freiburg, Germany
    Clin Nephrol 68:249-52. 2007
  7. ncbi Leflunomide therapy for polyomavirus-induced allograft nephropathy: efficient BK virus elimination without increased risk of rejection
    S Teschner
    Renal Division, Department of Medicine, University Hospital of Cologne, Cologne, Germany
    Transplant Proc 41:2533-8. 2009

Detail Information

Publications7

  1. ncbi Everolimus in patients with autosomal dominant polycystic kidney disease
    Gerd Walz
    Renal Division, University Hospital Freiburg, Hugstetter St, 55 79106 Freiburg, Germany
    N Engl J Med 363:830-40. 2010
    ..Experimental and observational studies suggest that the mammalian target of rapamycin (mTOR) pathway plays a critical role in cyst growth...
  2. ncbi [Organizational forms of emergency medicine from the viewpoint of hospital management. Discipline-specific or interdisciplinary?]
    G Walz
    Medizinische Klinik IV, Universitatsklinikum, Hugstetter Strasse 55, Freiburg, Germany
    Chirurg 82:342-7. 2011
    ..However, it appears reasonable to centralize all ER resources, to optimize the workflow using electronic patient charts and order entry sets and to incorporate the general practitioner into the treatment of simple medical problems...
  3. ncbi Rapidly progressive hepatic alveolar echinococcosis in an ABO-incompatible renal transplant recipient
    M Geyer
    Renal Division, University Hospital Freiburg, Freiburg, Germany
    Transpl Infect Dis 13:278-84. 2011
    ..This case documents an altered clinical course of the parasitosis and the challenge of serological diagnostic tools under an intensified regimen of immunosuppressive agents, including rituximab...
  4. ncbi ABO-incompatible kidney transplantation with antigen-specific immunoadsorption and rituximab - insights and uncertainties
    M Geyer
    University Hospital Freiburg, Freiburg, Germany
    Contrib Nephrol 162:47-60. 2009
    ....
  5. ncbi [Disseminated histoplasmosis with involvement of mediastinum and skin in an immunocompetent patient]
    R Wobser
    Abteilung für Nephrologie und Allgemeinmedizin, Medizinische Klinik IV, Universitatsklinikum Freiburg, Hugstetterstrasse 55, Freiburg
    Dtsch Med Wochenschr 134:589-93. 2009
    ..A 29-years-old Brazilian woman was admitted to hospital because of progressive dyspnoea, shivering and fever. She reported a noticeable swelling at the right mandible and an ulcerative tumor at the side of the nose...
  6. ncbi Nephrogenic systemic fibrosis following exposure to gadolinium-containing contrast agent
    S Clorius
    Department of Medicine, Renal Division, University Hospital Freiburg, Freiburg, Germany
    Clin Nephrol 68:249-52. 2007
    ..We provide a short overview and hope to raise overall awareness towards this entity and the use of MRA contrast agents in renal patients...
  7. ncbi Leflunomide therapy for polyomavirus-induced allograft nephropathy: efficient BK virus elimination without increased risk of rejection
    S Teschner
    Renal Division, Department of Medicine, University Hospital of Cologne, Cologne, Germany
    Transplant Proc 41:2533-8. 2009
    ..Leflunomide has immunosuppressive and antiviral properties and may be an alternative treatment agent. We report a two-center experience with use of leflunomide for treatment of PVAN...